The data from The Cancer Genome Atlas (TCGA) indicated that the SEPHS2 gene, which plays an important role in the selenoprotein synthesis pathway, is greatly upregulated in AML patients relative to healthy patients’ blood cells [168]. This evidence concerns the gene SELENOS and acute myeloid leukemia.